Literature DB >> 12756294

Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells.

Susanne I Wells1, Bruce J Aronow, Trisha M Wise, Sarah S Williams, Jennifer A Couget, Peter M Howley.   

Abstract

A frequent characteristic of human papillomavirus (HPV)-positive cervical cancers is the loss of viral E2 gene expression in HPV-infected cervical epithelial cells as a consequence of viral DNA integration into the cellular genome. The expression of E2 in HPV-positive cancer cells results in the repression of the viral E6/E7 oncogenes, activation of the p53 and pRB pathways, and a G1 cell cycle arrest, followed by induction of cellular senescence. The transcriptional consequences of E2-mediated cell cycle arrest that lead to senescence currently are unknown. Using conditional senescence induction in HeLa cells and microarray analysis, we describe here the expression profile of cells irreversibly committed to senescence. Our results provide insight into the molecular anatomy of senescence pathways and its regulation by HPV on-coproteins. These include the induction of the RAB vesicular transport machinery and a general down-regulation of chromatin regulatory molecules. The repression of tumor-specific G antigens during E2 senescence supports a reversal of the tumorigenic phenotype by E2 and the potential approach of tumor-specific G antigen-specific immunotherapy for cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12756294      PMCID: PMC165835          DOI: 10.1073/pnas.1232309100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.

Authors:  M Nees; J M Geoghegan; T Hyman; S Frank; L Miller; C D Woodworth
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 2.  Putting the stress on senescence.

Authors:  M Serrano; M A Blasco
Journal:  Curr Opin Cell Biol       Date:  2001-12       Impact factor: 8.382

3.  Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells.

Authors:  Y Terao; J Nishida; S Horiuchi; F Rong; Y Ueoka; T Matsuda; H Kato; Y Furugen; K Yoshida; K Kato; N Wake
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

Review 4.  Cellular senescence as a tumor-suppressor mechanism.

Authors:  J Campisi
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

5.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging.

Authors:  A Krtolica; S Parrinello; S Lockett; P Y Desprez; J Campisi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

6.  Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression.

Authors:  P Finzer; C Kuntzen; U Soto; H zur Hausen; F Rösl
Journal:  Oncogene       Date:  2001-08-09       Impact factor: 9.867

Review 7.  Ypt/rab gtpases: regulators of protein trafficking.

Authors:  N Segev
Journal:  Sci STKE       Date:  2001-09-18

8.  Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.

Authors:  A Nishimura; T Ono; A Ishimoto; J J Dowhanick; M A Frizzell; P M Howley; H Sakai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.

Authors:  E C Goodwin; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 10.  Cancer, aging and cellular senescence.

Authors:  J Campisi
Journal:  In Vivo       Date:  2000 Jan-Feb       Impact factor: 2.155

View more
  30 in total

1.  Integration of human papillomavirus 18 DNA in esophageal carcinoma 109 cells.

Authors:  Ke Zhang; Jin-Tao Li; Shu-Ying Li; Li-Hua Zhu; Ling Zhou; Yi Zeng
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.

Authors:  Monique A Morrison; Richard J Morreale; Shailaja Akunuru; Matthew Kofron; Yi Zheng; Susanne I Wells
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  Integration sites of human papillomavirus 18 in esophageal cancer samples.

Authors:  Shuying Li; Zhanjun Liu; Jianghong Yan; Shangbo Sun; Xiaoli Hou; Dianqing Liu; Ke Zhang; Jin-Tao Li
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

4.  NCoR1 mediates papillomavirus E8;E2C transcriptional repression.

Authors:  Maria L C Powell; Jennifer A Smith; Mathew E Sowa; J Wade Harper; Thomas Iftner; Frank Stubenrauch; Peter M Howley
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

5.  Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.

Authors:  Trisha M Wise-Draper; Hillary V Allen; Elizabeth E Jones; Kristen B Habash; Hiroshi Matsuo; Susanne I Wells
Journal:  Mol Cell Biol       Date:  2006-08-07       Impact factor: 4.272

6.  The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7.

Authors:  Trisha M Wise-Draper; Hillary V Allen; Megan N Thobe; Elizabeth E Jones; Kristen B Habash; Karl Münger; Susanne I Wells
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions.

Authors:  Ayodele Gomih; Jennifer S Smith; Kari E North; Michael G Hudgens; Wendy R Brewster; Zhiqing Huang; David Skaar; Fidel Valea; Rex C Bentley; Adriana C Vidal; Rachel L Maguire; Randy L Jirtle; Susan K Murphy; Cathrine Hoyo
Journal:  Int J Cancer       Date:  2018-03-30       Impact factor: 7.396

8.  Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

Authors:  Sang-Hyuk Chung; Paul F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

9.  Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2.

Authors:  Matthias Ottinger; Jennifer A Smith; Michal-Ruth Schweiger; Dana Robbins; Maria L C Powell; Jianxin You; Peter M Howley
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

10.  Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.

Authors:  Sang-Hyuk Chung; Kerri Wiedmeyer; Anny Shai; Kenneth S Korach; Paul F Lambert
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.